Home Tags ADC manufacturing

Tag: ADC manufacturing

Featured Image: Pellicon® Capsule. Courtesy: © 2019 MilliporeSigma. Used with permission.

Download the Application Note on the Pelicon® Capsule

Tangential flow filtration (TFF) is essential in the manufacturing of antibody drug conjugates (ADCs). Ultrafiltration (UF) is used to concentrate the protein product and...

Investing for the Future: Unlocking Advanced ADC Manufacturing Innovation

UPDATE: This event has been postponed until Fall 2019. Investment in ADCs (antibody-drug conjugates) has surged due to some very compelling market trends that include:...

ADC Biotechnology Secures UK £1.14 million Investment

ADC Biotechnology has successfully secured UK £1.14 million in funding from, Downing LLP, a London-based investment management firm.The company, founded in 2010, is developing...

Ajinomoto Althea Expected to Open New Manufacturing Facility for Antibody-drug Conjugate...

Biopharmaceutical contract development and manufacturing services company, Ajinomoto Althea confirmed that announced it will soon open a GMP production suite in its newly constructed...

Lonza – Celebrating 10 Years as ADC Manufacturing Pioneer

By leveraging the company's experience in biopharmaceuticals and small molecule drug process development and scale-up, Lonza has been successful in manufacturing antibody-drug conjugates, a...

Contract Manufacturing of Antibody-drug Conjugates – A Growing Market

The demand for manufacturing capacity of antibody-drug conjugates (ADCs), which includes a highly potent cytotoxic drug linked to a monoclonal antibody and have shown to...

Strategic Collaboration Between CMC Biologics and IDT Biologika to Manufacture Antibody...

Denmark-based CMC Biologics, a company involved in the clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika, a privately-held...

Q&A – an Interview with Lonza’s Laurent Ducry

Antibody-drug Conjugates or ADCs are among the most exciting drug developments of the last decade. The combination of potent, small molecule drugs with the...

CPhI Worldwide 2015, Antibody-drug Conjugates and Market Progression

Ahead of CPhI Worldwide 2015, CPhI expert panelist, Vivek Sharma, CEO of Pharma Solutions at Piramal, analyses the challenges in developing and manufacturing of...